Discussion # 1
Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 – 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.
Given your answer to Discussion Forum 1, discuss in 200 – 250 words what you believe Young Again Pharmaceuticals should focus on once the risks are mitigated.
If you need a copy of the Case 9-1 I can forward to you